Skip to main content

Table 5 Costs of attacks treated in compliance with the strategies

From: Value co-creation in healthcare: evidence from innovative therapeutic alternatives for hereditary angioedema

  Strategy 1 (home-based) Strategy 2 (hospital-based) Savings per attack
Total Per patient (N = 31) Per attack (N = 497) Total Per patient (N = 8) Per attack (N = 26)  
Medical costs (€)
Drug cost 608,399.00 19,625.77 1224.14 37,319.00 4664.88 1435.35  
ED visits 0 0 0 483.34 60.42 18.59  
Total 608,399.00 19,625.77 1224.14 37,802.34 4725.29 1453.94  
Non-medical costs (€)
Missed work/school days 13,737.47 443.14 27.64 5071.65 633.96 195.06  
Travel expenses 0 0 0 39.74 4.97 1.53  
Total 13,737.47 443.14 27.64 5111.39 638.92 196.59  
Payer perspective (€) 608,399.00 19,625.77 1224.14 37,802.34 4725.29 1453.94 229.8
Societal perspective (€) 622,136.47 20,068.92 1251.78 42,913.73 5364.22 1650.53 398.74